{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T07:38:42Z","timestamp":1740123522914,"version":"3.37.3"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2019,6,22]],"date-time":"2019-06-22T00:00:00Z","timestamp":1561161600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,6,22]],"date-time":"2019-06-22T00:00:00Z","timestamp":1561161600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Metab Brain Dis"],"published-print":{"date-parts":[[2019,10]]},"DOI":"10.1007\/s11011-019-00449-6","type":"journal-article","created":{"date-parts":[[2019,6,22]],"date-time":"2019-06-22T10:02:26Z","timestamp":1561197746000},"page":"1467-1472","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["The effect of hyperglycinemic treatment in captive-bred Vervet monkeys (Chlorocebus aethiops)"],"prefix":"10.1007","volume":"34","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4861-6018","authenticated-orcid":false,"given":"Zandisiwe E.","family":"Magwebu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mikateko","family":"Mazinu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sahar","family":"Abdul-Rasool","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chesa G.","family":"Chauke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,6,22]]},"reference":[{"key":"449_CR1","first-page":"702","volume":"15","author":"T Aghebati","year":"2012","unstructured":"Aghebati T, Foroughipour M, Azarpazhooh MR, Mokhber N, Khayat MH, Vahdati N, Mohammadpour AH (2012) Relationship between patient demographic characteristics, Valproic acid dosage and clearance in adult Iranian patients. Iran J Basic Med Sci 15:702","journal-title":"Iran J Basic Med Sci"},{"key":"449_CR2","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.seizure.2005.12.009","volume":"15","author":"SN Ahmed","year":"2006","unstructured":"Ahmed SN, Siddiqi ZA (2006) Antiepileptic drugs and liver disease. Seizure 15:156\u2013164","journal-title":"Seizure"},{"key":"449_CR3","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1002\/ajmg.a.31030","volume":"140","author":"DA Applegarth","year":"2006","unstructured":"Applegarth DA, Toone JR (2006) Glycine encephalopathy (nonketotic hyperglycinemia): comments and speculations. Am J Med Genet A 140:186\u2013188","journal-title":"Am J Med Genet A"},{"key":"449_CR4","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1023\/A:1005301321635","volume":"20","author":"G Arnold","year":"1997","unstructured":"Arnold G, Griebel M, Valentine J, Koroma D, Kearns G (1997) Dextromethorphan in nonketotic hyperglycinaemia: metabolic variation confounds the dose-response relationship. J Inherit Metab Dis 20:28\u201338","journal-title":"J Inherit Metab Dis"},{"key":"449_CR5","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.1007\/s12098-007-0212-x","volume":"74","author":"RP Bhamkar","year":"2007","unstructured":"Bhamkar RP, Colaco P (2007) Neonatal nonketotic hyperglycinemia. Indian J Pediatr 74:1124\u20131126","journal-title":"Indian J Pediatr"},{"key":"449_CR6","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1007\/s10038-005-0243-y","volume":"50","author":"A Boneh","year":"2005","unstructured":"Boneh A, Korman SH, Sato K, Kanno J, Matsubara Y, Lerer I, Ben-Neriah Z, Kure S (2005) A single nucleotide substitution that abolishes the initiator methionine codon of the GLDC gene is prevalent among patients with glycine encephalopathy in Jerusalem. J Hum Genet 50:230\u2013234","journal-title":"J Hum Genet"},{"key":"449_CR7","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.2217\/pgs.12.78","volume":"13","author":"D Chatzistefanidis","year":"2012","unstructured":"Chatzistefanidis D, Georgiou I, Kyritsis AP, Markoula S (2012) Functional impact and prevalence of polymorphisms involved in the hepatic glucuronidation of valproic acid. Pharmacogenomics 13:1055\u20131071","journal-title":"Pharmacogenomics"},{"key":"449_CR8","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1111\/jmp.12219","volume":"45","author":"CG Chauke","year":"2016","unstructured":"Chauke CG, Magwebu ZE, Sharma JR, Arieff Z, Seier JV (2016) Mutation analysis of GLDC, AMT and GCSH in cataract captive-bred vervet monkeys (Chlorocebus aethiops). J Med Primatol 45:189\u2013194","journal-title":"J Med Primatol"},{"key":"449_CR9","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.1098\/rstb.2010.0227","volume":"366","author":"A Churchill","year":"2011","unstructured":"Churchill A, Graw J (2011) Clinical and experimental advances in congenital and paediatric cataracts. Phil Trans R Soc B 366:1234\u20131249","journal-title":"Phil Trans R Soc B"},{"key":"449_CR10","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1002\/ajp.1037","volume":"55","author":"C De Villiers","year":"2001","unstructured":"De Villiers C, Seier JV, Dhansay MA (2001) Probable genetic origin for a large number of cataracts among captive-bred vervet monkeys (Chlorocebus aethiops). Am J Primatol 55:43\u201348","journal-title":"Am J Primatol"},{"key":"449_CR11","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1177\/088307389400900318","volume":"9","author":"MR Delgado","year":"1994","unstructured":"Delgado MR, Riela AR, Mills J, Browne R, Roach ES (1994) Thrombocytopenia secondary to high valproate levels in children with epilepsy. J Child Neurol 9:311\u2013314","journal-title":"J Child Neurol"},{"key":"449_CR12","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.ymgme.2005.07.016","volume":"86","author":"A Dinopoulos","year":"2005","unstructured":"Dinopoulos A, Matsubara Y, Kure S (2005) Atypical variants of nonketotic hyperglycinemia. Mol Genet Metab 86:61\u201369","journal-title":"Mol Genet Metab"},{"key":"449_CR13","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1002\/jat.1314","volume":"28","author":"P Espandiari","year":"2008","unstructured":"Espandiari P, Zhang J, Schnackenberg LK, Miller TJ, Knapton A, Herman EH, Beger RD, Hanig JP (2008) Age-related differences in susceptibility to toxic effects of valproic acid in rats. J Appl Toxicol 28:628\u2013637","journal-title":"J Appl Toxicol"},{"key":"449_CR14","first-page":"1082","volume":"26","author":"Z Gregus","year":"1998","unstructured":"Gregus Z, Fekete T, Hal\u00e1szi \u00c9, Gyurasics \u00c1, Klaassen CD (1998) Effects of fibrates on the glycine conjugation of benzoic acid in rats. Drug Metab Dispos 26:1082\u20131088","journal-title":"Drug Metab Dispos"},{"key":"449_CR15","doi-asserted-by":"publisher","first-page":"536","DOI":"10.2133\/dmpk.DMPK-11-NT-144","volume":"27","author":"Y Guo","year":"2012","unstructured":"Guo Y, Hu C, He X, Qiu F, Zhao L (2012) Effects of UGT1A6, UGT2B7, and CYP2C9 genotypes on plasma concentrations of valproic acid in Chinese children with epilepsy. Drug Metab Pharmacokinet 27:536\u2013542","journal-title":"Drug Metab Pharmacokinet"},{"key":"449_CR16","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/S0022-3476(05)82559-4","volume":"121","author":"A Hamosh","year":"1992","unstructured":"Hamosh A, Mcdonald JW, Valle D, Francomano CA, Niedermeyer E, Johnston MV (1992) Dextromethorphan and high-dose benzoate therapy for nonketotic hyperglycinemia in an infant. J Pediatr 121:131\u2013135","journal-title":"J Pediatr"},{"key":"449_CR17","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1016\/S0022-3476(98)70365-8","volume":"132","author":"A Hamosh","year":"1998","unstructured":"Hamosh A, Maher JF, Bellus GA, Rasmussen SA, Johnston MV (1998) Long-term use of high-dose benzoate and dextromethorphan for the treatment of nonketotic hyperglycinemia. J Pediatr 132:709\u2013713","journal-title":"J Pediatr"},{"key":"449_CR18","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/0387-7604(95)00139-5","volume":"18","author":"E Hauser","year":"1996","unstructured":"Hauser E, Seidl R, Freilinger M, Male C, Herkner K (1996) Hematologic manifestations and impaired liver synthetic function during valproate monotherapy. Brain Dev 18:105\u2013109","journal-title":"Brain Dev"},{"key":"449_CR19","doi-asserted-by":"crossref","unstructured":"Hejtmancik J. F. Congenital cataracts and their molecular genetics. Semin Cell Dev Biol, 2008. Elsevier, 134\u2013149","DOI":"10.1016\/j.semcdb.2007.10.003"},{"key":"449_CR20","doi-asserted-by":"publisher","first-page":"621.630","DOI":"10.2217\/14796708.1.5.621","volume":"1","author":"JB Hennermann","year":"2006","unstructured":"Hennermann JB (2006) Clinical variability in glycine encephalopathy. Future Neurol 1:621.630","journal-title":"Future Neurol"},{"key":"449_CR21","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1007\/s10545-011-9398-1","volume":"35","author":"JB Hennermann","year":"2012","unstructured":"Hennermann JB, Berger JM, Grieben U, Scharer G, Van Hove JL (2012) Prediction of long-term outcome in glycine encephalopathy: a clinical survey. J Inherit Metab Dis 35:253\u2013261","journal-title":"J Inherit Metab Dis"},{"key":"449_CR22","doi-asserted-by":"publisher","first-page":"1847","DOI":"10.1212\/01.WNL.0000144270.83080.29","volume":"63","author":"JE Hoover-Fong","year":"2004","unstructured":"Hoover-Fong JE, Shah S, Van Hove JL, Applegarth D, Toone J, Hamosh A (2004) Natural history of nonketotic hyperglycinemia in 65 patients. Neurology 63:1847\u20131853","journal-title":"Neurology"},{"key":"449_CR23","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.2217\/pgs.11.64","volume":"12","author":"C-C Hung","year":"2011","unstructured":"Hung C-C, Ho J-L, Chang W-L, Tai JJ, Hsieh T-J, Hsieh Y-W, Liou H-H (2011) Association of genetic variants in six candidate genes with valproic acid therapy optimization. Pharmacogenomics 12:1107\u20131117","journal-title":"Pharmacogenomics"},{"key":"449_CR24","doi-asserted-by":"crossref","unstructured":"Hussain S, Mordekar S, Prasad M (2013) The calm before the storm?: late onset Glycine encephalopathy masquerading as gastro-oesophageal reflux. J Neurodev Disord 2013","DOI":"10.4172\/2329-6895.1000104"},{"key":"449_CR25","first-page":"539","volume":"25","author":"A Karaoglu","year":"2009","unstructured":"Karaoglu A, Vurucu S, Okutan V, Kurekci AE, Cayc\u00fd T, Atay A, Akin R, Gokcay E (2009) Valporic acid: is it safe to use in epileptic pediatric patient? Pak J Med Sci July\u2013September 25:539\u2013544","journal-title":"Pak J Med Sci July\u2013September"},{"key":"449_CR26","doi-asserted-by":"publisher","first-page":"2027","DOI":"10.1111\/j.1528-1167.2006.00846.x","volume":"47","author":"SA Koenig","year":"2006","unstructured":"Koenig SA, Buesing D, Longin E, Oehring R, H\u00e4ussermann P, Kluger G, Lindmayer F, Hanusch R, Degen I, Kuhn H (2006) Valproic acid\u2013induced Hepatopathy: nine new fatalities in Germany from 1994 to 2003. Epilepsia 47:2027\u20132031","journal-title":"Epilepsia"},{"key":"449_CR27","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1203\/PDR.0b013e3181799562","volume":"64","author":"K Kojima-Ishii","year":"2008","unstructured":"Kojima-Ishii K, Kure S, Ichinohe A, Shinka T, Narisawa A, Komatsuzaki S, Kanno J, Kamada F, Aoki Y, Yokoyama H (2008) Model mice for mild-form glycine encephalopathy: behavioral and biochemical characterizations and efficacy of antagonists for the glycine binding site of N-methyl D-aspartate receptor. Pediatr Res 64:228\u2013233","journal-title":"Pediatr Res"},{"key":"449_CR28","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1002\/humu.20293","volume":"27","author":"S Kure","year":"2006","unstructured":"Kure S, Kato K, Dinopoulos A, Gail C, Degrauw TJ, Christodoulou J, Bzduch V, Kalmanchey R, Fekete G, Trojovsky A (2006) Comprehensive mutation analysis of GLDC, AMT, and GCSH in nonketotic hyperglycinemia. Hum Mutat 27:343\u2013352","journal-title":"Hum Mutat"},{"key":"449_CR29","doi-asserted-by":"publisher","first-page":"537","DOI":"10.3109\/14767058.2012.745496","volume":"26","author":"AE Madu","year":"2013","unstructured":"Madu AE, Oliver L (2013) Non-ketotic hyperglycinaemia: case report and review of medical literature. J Matern Fetal Neonatal Med 26:537\u2013539","journal-title":"J Matern Fetal Neonatal Med"},{"key":"449_CR30","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1111\/jmp.12332","volume":"47","author":"ZE Magwebu","year":"2018","unstructured":"Magwebu ZE, Abdul-Rasool S, Seier JV, Chauke CG (2018) Autosomal recessive congenital cataract in captive-bred vervet monkeys (Chlorocebus aethiops). J Med Primatol 47:93\u2013100","journal-title":"J Med Primatol"},{"key":"449_CR31","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1111\/j.1528-1167.2007.01429.x","volume":"49","author":"W Nasreddine","year":"2008","unstructured":"Nasreddine W, Beydoun A (2008) Valproate-induced thrombocytopenia: a prospective monotherapy study. Epilepsia 49:438\u2013445","journal-title":"Epilepsia"},{"key":"449_CR32","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1023\/A:1005642728513","volume":"23","author":"JM Neuberger","year":"2000","unstructured":"Neuberger JM, Schweitzer S, Rolland MO, Burghard R (2000) Effect of sodium benzoate in the treatment of atypical nonketotic hyperglycinaemia. J Inherit Metab Dis 23:22\u201326","journal-title":"J Inherit Metab Dis"},{"key":"449_CR33","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1007\/s11832-012-0407-1","volume":"6","author":"N Ramirez","year":"2012","unstructured":"Ramirez N, Flynn JM, Casalduc F, Rodriguez S, Cornier AS, Carlo S (2012) Musculoskeletal manifestations of neonatal nonketotic hyperglycinemia. J Child Orthop 6:199\u2013203","journal-title":"J Child Orthop"},{"key":"449_CR34","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1023\/A:1005667707355","volume":"23","author":"C Randak","year":"2000","unstructured":"Randak C, Roschinger W, Rolinski B, Hadorn HB, Applegarth DA, Roscher AA (2000) Three siblings with nonketotic hyperglycinaemia, mildly elevated plasma homocysteine concentrations and moderate methylmalonic aciduria. J Inherit Metab Dis 23:520\u2013522","journal-title":"J Inherit Metab Dis"},{"key":"449_CR35","doi-asserted-by":"publisher","first-page":"378","DOI":"10.5144\/0256-4947.2004.378","volume":"24","author":"D Roy","year":"2003","unstructured":"Roy D, Al-Asmari A, Ghazal Y, Al-Oqiel S (2003) Nonketotic hyperglycinemia in Suleimaniah Children's hospital, Riyadh, Saudi Arabia. Ann Saudi Med 24:378\u2013381","journal-title":"Ann Saudi Med"},{"key":"449_CR36","volume-title":"Valproic acid and fatalities in children: a review of individual case safety reports in VigiBase","author":"K Star","year":"2014","unstructured":"Star K., Edwards I. R.. Choonara I. (2014). Valproic acid and fatalities in children: a review of individual case safety reports in VigiBase"},{"key":"449_CR37","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1007\/s10545-005-0033-x","volume":"28","author":"JL Van Hove","year":"2005","unstructured":"Van Hove JL, Vande Kerckhove K, Hennermann JB, Mahieu V, Declercq P, Mertens S, De Becker M, Kishnani PS, Jaeken J (2005) Benzoate treatment and the glycine index in nonketotic hyperglycinaemia. J Inherit Metab Dis 28:651\u2013663","journal-title":"J Inherit Metab Dis"},{"key":"449_CR38","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1007\/s11011-012-9285-y","volume":"27","author":"J Viljoen","year":"2012","unstructured":"Viljoen J, Bergh JJ, Mienie LJ, Kotze HF, Terre\u2019blanche G (2012) Paracetamol prevents hyperglycinemia in vervet monkeys treated with valproate. Metab Brain Dis 27:327\u2013335","journal-title":"Metab Brain Dis"}],"container-title":["Metabolic Brain Disease"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11011-019-00449-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11011-019-00449-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11011-019-00449-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,6,20]],"date-time":"2020-06-20T23:18:03Z","timestamp":1592695083000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11011-019-00449-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6,22]]},"references-count":38,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2019,10]]}},"alternative-id":["449"],"URL":"https:\/\/doi.org\/10.1007\/s11011-019-00449-6","relation":{},"ISSN":["0885-7490","1573-7365"],"issn-type":[{"type":"print","value":"0885-7490"},{"type":"electronic","value":"1573-7365"}],"subject":[],"published":{"date-parts":[[2019,6,22]]},"assertion":[{"value":"24 October 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 June 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 June 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study was approved by the SAMRC Ethics Committee for Research on Animals (ECRA) (Ref.08\/13). All procedure performed in study involving animals were in accordance with the ethical standards of the South African National Standard for the Care and Use of Animals for Scientific Purposes (South African Bureau of Standards, SANS 10386, 2008).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}